130 related articles for article (PubMed ID: 15188729)
1. Clinical management. Where medicine meets management. Pumping iron.
Peebles G
Health Serv J; 2004 May; 114(5907):28-9. PubMed ID: 15188729
[TBL] [Abstract][Full Text] [Related]
2. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
Bhandari S; Naudeer S
J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
[TBL] [Abstract][Full Text] [Related]
3. Addressing patient concerns about intravenous iron therapy.
Robbins KC
Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
[TBL] [Abstract][Full Text] [Related]
4. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.
Bistrian BR; Carey LA
Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343
[TBL] [Abstract][Full Text] [Related]
5. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients.
Peacock E; Lindenfeld SM
ANNA J; 1999 Jun; 26(3):337-43. PubMed ID: 10633605
[TBL] [Abstract][Full Text] [Related]
6. Maintaining iron balance with total-dose infusion of intravenous iron dextran.
Case G
ANNA J; 1998 Feb; 25(1):65-8. PubMed ID: 9543911
[TBL] [Abstract][Full Text] [Related]
7. Iron requirements in hemodialysis.
Sargent JA; Acchiardo SR
Blood Purif; 2004; 22(1):112-23. PubMed ID: 14732819
[TBL] [Abstract][Full Text] [Related]
8. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment.
Senger JM; Weiss RJ
ANNA J; 1996 Jun; 23(3):319-23; discussion 324-5. PubMed ID: 8716991
[TBL] [Abstract][Full Text] [Related]
9. [Principles of iron therapy in hemodialysis patients].
Basić-Jukić N; Kes P; Jurić I
Acta Med Croatica; 2006 Dec; 60(5):457-62. PubMed ID: 17217102
[TBL] [Abstract][Full Text] [Related]
10. Total quality improvement assessment of the EPO co-ordinator role.
Morrison EA
EDTNA ERCA J; 1999; 25(4):8-10. PubMed ID: 10827589
[TBL] [Abstract][Full Text] [Related]
11. Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.
Mittman N
Am J Kidney Dis; 1999 Jul; 34(1):173-6. PubMed ID: 10401035
[No Abstract] [Full Text] [Related]
12. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
13. Past, present, and future of chronic kidney disease anemia management in the United States.
Wish JB
Adv Chronic Kidney Dis; 2009 Mar; 16(2):101-8. PubMed ID: 19233069
[TBL] [Abstract][Full Text] [Related]
14. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.
Berns JS; Mosenkis A
Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients].
López T; Almirall J; Calvet X; Quesada M; Sanfeliú I; Segura F; García M
Nefrologia; 2006; 26(6):673-8. PubMed ID: 17227244
[TBL] [Abstract][Full Text] [Related]
18. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron therapy in end-stage renal disease.
Brewster UC
Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
